Qiagen NV (LTS:0RLT) Institutional Ownership : 57.43% (As of May. 20, 2024)

View and export this data going back to 2008. Start your Free Trial

What is Qiagen NV Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Qiagen NV's institutional ownership is 57.43%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Qiagen NV's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Qiagen NV's Float Percentage Of Total Shares Outstanding is 76.39%.

Qiagen NV Institutional Ownership Historical Data

The historical data trend for Qiagen NV's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qiagen NV Institutional Ownership Chart

Qiagen NV Historical Data

The historical data trend for Qiagen NV can be seen below:

	2023-07-31	2023-08-31	2023-09-30	2023-10-31	2023-11-30	2023-12-31	2024-01-31	2024-02-29	2024-03-31	2024-04-30
Institutional Ownership	57.06	56.17	55.86	55.06	55.67	57.56	56.12	56.78	57.72	57.43

Qiagen NV Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

Qiagen NV (LTS:0RLT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Qiagen NV (LTS:0RLT) » Definitions » Institutional Ownership

Comparable Companies

EXAS NTRA CRL MEDP RVTY RDNT DGX SHC NEOG GH TMO DHR IQV XSWX:LONN IDXX A MTD ICLR ILMN WAT

Traded in Other Exchanges

QGEN:USA 1QGEN:Italy QIAd:UK QIA:Germany QGEN:Austria

Address

Hulsterweg 82, Venlo, LI, NLD, 5912 PL

Website

https://www.qiagen.com

Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (over 45% of 2022 sales), followed by EMEA (nearly 35%), and Asia-Pacific (nearly 20%).

Qiagen NV (LTS:0RLT) Headlines

No Headlines